Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Electronic Health Records × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Hematologic Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Small Intestinal Neuroendocrine Tumor 1 Papillomavirus Infections 1 Pancreatic Adenocarcinoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Heart Failure 1 Cystic Fibrosis 1 Cardiomyopathies 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Surveys and Questionnaires 114 Exercise 102 Blood Specimen Collection 98 Radiotherapy 66 Gemcitabine 64 Bevacizumab 57 Cisplatin 55 Standard of Care 54 Cyclophosphamide 51 Capecitabine 50 Carboplatin 49 Docetaxel 47 Dexamethasone 46 pembrolizumab 45 Paclitaxel 45 Interviews as Topic 43 Oxaliplatin 40 Magnetic Resonance Spectroscopy 38 Fluorouracil 37 Methods 36 Irinotecan 36 Therapeutics 33 Drug Therapy 32 Radiosurgery 31 Nivolumab 30 Erlotinib Hydrochloride 27 Educational Status 26 Everolimus 24 Leucovorin 23 Control Groups 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04445870 2022-07-11

ONCOCARE-COV

CHU de Reims

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡